Meeting report: Biochemical aspects of schizophrenia. Alabama, April 1975.
D000208:Acute Disease; D001792:Blood Platelets / Q000201:enzymology; D002908:Chronic Disease; D004298:Dopamine / Q000378:metabolism; D005492:Folic Acid / Q000378:metabolism; D006213:Hallucinogens; D006801:Humans; D008636:Mesencephalon / Q000378:metabolism; D008715:Methionine / Q000627:therapeutic use; D008995:Monoamine Oxidase / Q000097:blood; D011388:Prolactin; D011954:Receptors, Dopamine / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D013601:T-Lymphocytes / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D006213:Hallucinogens; D011954:Receptors, Dopamine; D012701:Serotonin; D005680:gamma-Aminobutyric Acid; D011388:Prolactin; D005492:Folic Acid; D008715:Methionine; D008995:Monoamine Oxidase; D004298:Dopamine